<scp>PI</scp>3K/Akt/<scp>mTOR</scp> pathway dual inhibitor <scp>BEZ</scp>235 suppresses the stemness of colon cancer stem cells
Jiezhong Chen(University of Pittsburgh), Wenyi Gu(Qinghai University)
Cited by 98
Related Papers
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
|Annals of Oncology|2015|761
PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
|Frontiers in Immunology|2019|411
Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells
|BMC Cancer|2019|54
Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis
|International Journal of Nanomedicine|2016|52